These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 17726160)

  • 21. Chromosomal abnormalities in primary myelodysplastic syndrome.
    Rashid A; Khurshid M; Shaikh U; Adil S
    J Coll Physicians Surg Pak; 2014 Sep; 24(9):632-5. PubMed ID: 25233965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytogenetic abnormalities in Tunisian de novo myelodysplastic syndrome: a comparison with other populations.
    Gmidène A; Sennana H; Fenaux P; Laatiri A; Zarrouk M; Bouaziz H; Harrabi I; Saad A
    Leuk Res; 2008 Dec; 32(12):1824-9. PubMed ID: 18556065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytogenetic features in myelodysplastic syndromes.
    Haase D
    Ann Hematol; 2008 Jul; 87(7):515-26. PubMed ID: 18414863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relapse and cytogenetic evolution in myeloid neoplasms.
    Ertz-Archambault N; Kelemen K
    Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes.
    Solé F; Prieto F; Badia L; Woessner S; Florensa L; Caballin MR; Coll MD; Besses C; Sans-Sabrafen J
    Cancer Genet Cytogenet; 1992 Nov; 64(1):12-20. PubMed ID: 1458444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone marrow karyotype and prognosis in primary myelodysplastic syndromes.
    Billström R; Thiede T; Hansen S; Heim S; Kristoffersson U; Mandahl N; Mitelman F
    Eur J Haematol; 1988 Oct; 41(4):341-6. PubMed ID: 3197821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlations between cytogenetics and morphology in myelodysplastic syndromes.
    Vila L; Charrin C; Archimbaud E; Treille-Ritouet D; Fraisse J; Felman P; Fiere D; Germain D
    Blut; 1990 Apr; 60(4):223-7. PubMed ID: 2337681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype.
    Rigolin GM; Bigoni R; Milani R; Cavazzini F; Roberti MG; Bardi A; Agostini P; Della Porta M; Tieghi A; Piva N; Cuneo A; Castoldi G
    Leukemia; 2001 Dec; 15(12):1841-7. PubMed ID: 11753603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytogenetic as an important tool for diagnosis and prognosis for patients with hypocellular primary myelodysplastic syndrome.
    de Souza DC; Fernandez Cde S; Camargo A; Apa AG; da Costa ES; Bouzas LF; Abdelhay E; Fernandez Tde S
    Biomed Res Int; 2014; 2014():542395. PubMed ID: 25180186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognosis of patients with del(5q) MDS and complex karyotype and the possible role of lenalidomide in this patient subgroup.
    Giagounidis AA; Germing U; Strupp C; Hildebrandt B; Heinsch M; Aul C
    Ann Hematol; 2005 Sep; 84(9):569-71. PubMed ID: 15891887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Detection of cytogenetic abnormalities involving chromosomes 5,7 and 8 in myelodysplastic syndromes with fluorescence in situ hybridization and its clinical significance].
    Cai Y; Qin YW; Wang C; Yang J; Yan SK
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jan; 28(1):6-10. PubMed ID: 17649717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [WHO classification and cytogenetic analysis of 435 cases with myelodysplastic syndrome].
    Wang XQ;
    Zhonghua Nei Ke Za Zhi; 2008 Jun; 47(6):464-7. PubMed ID: 19040061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic impact of karyotypic subgroups in myelodysplastic syndromes is strongly modified by sex.
    Mauritzson N; Johansson B; Rylander L; Albin M; Strömberg U; Billström R; Ahlgren T; Mikoczy Z; Mitelman F; Hagmar L; Nilsson PG
    Br J Haematol; 2001 May; 113(2):347-56. PubMed ID: 11380398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytogenetic findings in adult greek myelodysplastic syndrome patients: predominance of single trisomy 8.
    Panani AD
    In Vivo; 2006; 20(1):115-8. PubMed ID: 16433038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Better prognosis for patients with del(7q) than for patients with monosomy 7 in myelodysplastic syndrome.
    Cordoba I; González-Porras JR; Nomdedeu B; Luño E; de Paz R; Such E; Tormo M; Vallespi T; Collado R; Xicoy B; Andreu R; Muñoz JA; Solé F; Cervera J; del Cañizo C;
    Cancer; 2012 Jan; 118(1):127-33. PubMed ID: 21717439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytogenetic aspects of adult primary myelodysplastic syndromes: clinical implications.
    Panani AD; Roussos C
    Cancer Lett; 2006 Apr; 235(2):177-90. PubMed ID: 15935553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prognostic impact of separation of refractory cytopenia with multilineage dysplasia and 5q- syndrome from refractory anemia in primary myelodysplastic syndrome.
    Cermák J; Michalová K; Brezinová J; Zemanová Z
    Leuk Res; 2003 Mar; 27(3):221-9. PubMed ID: 12537974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis of Cytogenetic Characteristics and Clinical Prognosis in 236 Patients with Myelodysplastic Syndrome].
    Xia JY; Wang Y; Li DP; Li ZY; Qiu TT; Xu KL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1190-1195. PubMed ID: 31418378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromosomal alterations associated with evolution from myelodysplastic syndrome to acute myeloid leukemia.
    de Souza Fernandez T; Ornellas MH; Otero de Carvalho L; Tabak D; Abdelhay E
    Leuk Res; 2000 Oct; 24(10):839-48. PubMed ID: 10996202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001.
    Mauritzson N; Albin M; Rylander L; Billström R; Ahlgren T; Mikoczy Z; Björk J; Strömberg U; Nilsson PG; Mitelman F; Hagmar L; Johansson B
    Leukemia; 2002 Dec; 16(12):2366-78. PubMed ID: 12454741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.